Biomerica Inc (BMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
(Values in U.S. thousands)
| 05-2025 | 05-2024 | 05-2023 | 05-2022 | 05-2021 | |
| Sales | 5,311 | 5,415 | 5,339 | 18,871 | 7,199 |
| Cost of Goods | 4,813 | 4,804 | 4,893 | 15,894 | 6,833 |
| Gross Profit | 498 | 611 | 446 | 2,977 | 366 |
| Operating Expenses | 6,448 | 7,782 | 8,562 | 8,405 | 8,699 |
| Operating Income | -5,137 | -6,367 | -7,223 | -4,534 | -7,500 |
| Other Income | 165 | 431 | 134 | 27 | 67 |
| Pre-tax Income | -4,972 | -5,936 | -7,089 | -4,507 | -7,433 |
| Income Tax | 1 | 42 | 51 | 24 | 13 |
| Net Income Continuous | -4,973 | -5,978 | -7,140 | -4,531 | -7,446 |
| Net Income | $-4,973 | $-5,978 | $-7,140 | $-4,531 | $-7,446 |
| EPS Basic Total Ops | -2.16 | -2.84 | -4.00 | -2.88 | -4.96 |
| EPS Basic Continuous Ops | -2.16 | -2.84 | -4.04 | -2.86 | -4.99 |
| EPS Diluted Total Ops | -2.16 | -2.84 | -4.00 | -2.88 | -4.96 |
| EPS Diluted Continuous Ops | -2.16 | -2.84 | -4.04 | -2.86 | -4.99 |
| EPS Diluted Before Non-Recurring Items | -2.16 | -2.88 | -4.00 | -2.88 | -4.32 |
| EBITDA(a) | $-4,737 | $-5,993 | $-6,872 | $-3,939 | $-7,124 |